ZandCell COVID-19 Vaccine Companion Test
A person’s immune system produces antibodies to combat the virus after vaccination.
The assay is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of neutralizing antibodies after vaccination to SARS-CoV-2 in human whole blood, serum or plasma.
The limit of detection has been evaluated at 0.1 ng/mL.
Sample size: 100